ArticlePharmaceutics2025

Intra-Arterial Super-Selective Delivery of Yttrium-90 for the Treatment of Recurrent Glioblastoma: In Silico Proof of Concept with Feasibility and Safety Analysis.

Giulia Paolani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.